alexa Reviewer - Ao Li | Yale University School of Medicine | 8079
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ao Li

Department of Pharmacology
Yale University School of Medicine
Room 320 Amistad Research Building
10 Amistad Street
New haven, CT, 06520
USA Official e-mail address: [email protected] 

Biography

Dr. Li received Ph.D. from Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing, China and has worked in the field of kidney disease for almost 10 years and published several papers in different journals as first author or co-responding author. She has strong background and expertise and experiences in am working on elucidating the molecular mechanisms and pathogenesis of Polycystic Kidney Disease (PKD) and has worked in Prof. Guanqing Wu’s Lab in Division of Translational Cancer Research and Therapy, State Key Laboratory of Molecular Oncology of Cancer Institute. Her research focused on the application of molecular technology and well-extended genetic knowledge to unravel the pathogenesis and molecular mechanism of human genetic-related diseases. She have strong background and experiences in elucidating the molecular mechanisms and pathogenesis of human genetic disease: autosomal dominant polycystic disease (ADPKD) and autosomal recessive polycystic disease (ARPKD).

Research Interest

My research focused on the application of molecular technology and well-extended genetic knowledge to unravel the pathogenesis and molecular mechanism of human genetic-related diseases. With strong background and experiences, I have elucidate the molecular mechanisms and pathogenesis of human genetic disease: autosomal dominant polycystic disease (ADPKD) and autosomal recessive polycystic disease (ARPKD). I am also engaged in the application of translational medicine to treat PKD based on my PKD research.

Top